Healthcare -
Biotechnology - NASDAQ - US
$ 12.29
-8.31 %
$ 1 B
Market Cap
-3.92
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Viridian Therapeutics, Inc.
| Revenue | 302 K |
| Cost Of Revenue | 1.24 M |
| Gross Profit | -938 K |
| Operating Expenses | 299 M |
| Operating Income | -299 M |
| Other Expenses | -29.1 M |
| Net Income | -270 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||
| Revenue | 0.3 | 0.3 | 1.8 | 3.0 | 1.1 | 4.5 | 8.4 | 4.0 | 3.3 | 2.5 | 4.3 | 4.3 | 4.4 |
| GROSS PROFIT | |||||||||||||
| Cost Of Revenue | 1.2 | 1.3 | 0.8 | 0.6 | 28.3 | 32.8 | 30.4 | 19.6 | 2.5 | 2.5 | 3.2 | 2.5 | 3.0 |
| Gross Profit | (0.9) | (1.0) | 1.0 | 2.3 | (27.3) | (28.3) | (22.0) | (15.6) | 0.8 | 66 K | 1.1 | 1.8 | 1.4 |
| OPERATING INCOME | |||||||||||||
| Operating Expenses | 299.3 | 254.8 | 136.1 | 82.7 | 41.6 | 46.4 | 41.5 | 30.5 | 10.5 | 11.3 | 8.0 | 2.3 | 4.5 |
| Selling, General and Administrative Expenses | 61.1 | 95.0 | 35.2 | 25.8 | 13.3 | 11.6 | 11.0 | 10.9 | 9.6 | 10.3 | 7.8 | 2.2 | 4.2 |
| Research and Development Expenses | 238.3 | 159.8 | 100.9 | 56.9 | 28.3 | 34.8 | 30.4 | 19.6 | 0.9 | 1.0 | 0.3 | 96.8 K | 0.2 |
| Operating Income | (299.0) | (254.4) | (134.3) | (79.7) | (110.4) | (42.0) | (33.1) | (26.5) | (12.5) | (11.2) | (6.9) | (0.2) | (4.0) |
| PRE-TAX INCOME | |||||||||||||
| Interest Income Expense | 3.0 | 1.8 | 0.5 | 3 K | 0.5 | 0.8 | 0.9 | 0.4 | 95 K | 0.1 | 1.0 | 2.0 | 1.6 |
| Total Other Income | 29.1 | 16.7 | 4.4 | 0.3 | (0.3) | 0.1 | 0.4 | 20 K | (0.2) | (0.1) | (1.0) | (1.7) | (1.6) |
| Pre-Tax Income | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (5.6) |
| NET INCOME | |||||||||||||
| Tax Provision | 0 | 0 | (4.4) | 3 K | 0.3 | 0.5 | 1.3 | 95 K | 95 K | 0 | 1.0 | 2.0 | 3.2 |
| Net Income | (269.9) | (237.7) | (125.4) | (79.4) | (111.0) | (42.4) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (7.2) |
| EPS | 3.98 | 5.31 | 3.91 | 6.66 | 31.2 | 20.3 | 16.6 | 20.7 | 17.6 | 21 | 52.5 | 11.5 | 38.8 |